title: Triptans in prevention of menstrual migraine: a systematic review with meta-analysis.
abstract: Randomized clinical trials (RCT) assessing the efficacy and tolerability of triptans compared with placebo as short-term prophylaxis of menstrual migraine (MM) were systematically reviewed in this study. Triptans, which interfere with the pathogenesis of migraine and are effective in relieving associated neurovegetative symptoms, have been extensively proposed for prevention of menstrual migraine attacks. We searched Cochrane CENTRAL, MEDLINE and EMBASE for randomized, double-blind, placebo-controlled trials on triptans for MM until 1 Oct, 2012. A total of six RCTs were identified. Two authors independently assessed trial's quality and extracted data. Numbers of participants free from MM per perimenstrual period (PMP), requiring rescue medication, suffering from headache-associated symptoms and experiencing adverse events in treatment and control groups were used to calculate relative risk (RR) and number needed to treat (NNT) with their corresponding 95% confidence interval (CI). A total of 633 participants received frovatriptan 2.5 mg QD, 584 received frovatriptan 2.5 mg BID, 392 received naratriptan 1 mg BID, 70 received naratriptan 2.5 mg BID, 80 received zolmitriptan 2.5 mg BID, 83 received zolmitriptan 2.5 mg TID and 1104 received placebo. Overall, triptans is an effective, short-term, prophylactic treatment of choice for MM. Considering MM frequency, severity and adverse events, frovatriptan 2.5 mg BID and zolmitriptan 2.5 mg TID tend to be the preferred regimens.
authors.affiliation: Department of neurology, Shanghai Tongji Hospital, Tongji University School of Medicine, Xin-Cun Road 389, Shanghai, 200065, China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Hu
authors.forename: Xiaofei
authors.initials: X
authors.lastname: Guan
authors.forename: Lin
authors.initials: L
authors.lastname: Fan
authors.forename: Lingjing
authors.initials: L
authors.lastname: Jin
mesh_terms: D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000502:physiology*; D008598:Menstruation / Q000502:physiology; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology*; D016032:Randomized Controlled Trials as Topic; D014363:Tryptamines / Q000627:therapeutic use*
chemical_list: D014363:Tryptamines
references.citation: Headache. 2007 Jun;47(6):886-94
references.pmid: 17578540
references.citation: Continuum (Minneap Minn). 2012 Aug;18(4):764-82
references.pmid: 22868540
references.citation: Control Clin Trials. 1996 Feb;17(1):1-12
references.pmid: 8721797
references.citation: Neurology. 2006 Dec 26;67(12):2159-63
references.pmid: 17190936
references.citation: Expert Opin Drug Metab Toxicol. 2012 Aug;8(8):1043-50
references.pmid: 22762358
references.citation: Acta Anaesthesiol Taiwan. 2012 Jun;50(2):69-73
references.pmid: 22769861
references.citation: J Headache Pain. 2012 Jul;13(5):401-6
references.pmid: 22592864
references.citation: Headache. 2001 Mar;41(3):248-56
references.pmid: 11264684
references.citation: Curr Pain Headache Rep. 2010 Oct;14(5):385-8
references.pmid: 20697844
references.citation: CNS Drugs. 2006;20(12):1019-26
references.pmid: 17140280
references.citation: Headache. 2004 Feb;44(2):160-5
references.pmid: 14756855
references.citation: Curr Pain Headache Rep. 2010 Oct;14(5):389-95
references.pmid: 20625856
references.citation: Headache. 2007 Jul-Aug;47(7):1037-49
references.pmid: 17635595
references.citation: J Headache Pain. 2012 Jul;13(5):339-49
references.pmid: 22535147
references.citation: Headache. 2009 Oct;49(9):1283-97
references.pmid: 19751371
references.citation: Cephalalgia. 2009 Nov;29(11):1133-48
references.pmid: 19811503
references.citation: Gynecol Endocrinol. 2010 Oct;26(10):773-9
references.pmid: 20528213
references.citation: CNS Drugs. 2008;22(10):877-86
references.pmid: 18788838
references.citation: Cephalalgia. 2011 Jan;31(2):152-60
references.pmid: 20650999
references.citation: Drugs. 1993;46 Suppl 1:140-1
references.pmid: 7506154
references.citation: Headache. 2008 Nov-Dec;48 Suppl 3:S124-30
references.pmid: 19076658
references.citation: J Headache Pain. 2011 Aug;12(4):399-403
references.pmid: 21437713
references.citation: Expert Rev Neurother. 2007 Sep;7(9):1105-20
references.pmid: 17868010
references.citation: Continuum (Minneap Minn). 2012 Aug;18(4):753-63
references.pmid: 22868539
references.citation: J Headache Pain. 2007 Oct;8(5):283-8
references.pmid: 17955167
references.citation: Womens Health (Lond). 2012 Sep;8(5):529-41
references.pmid: 22934727
references.citation: J Headache Pain. 2010 Feb;11(1):33-44
references.pmid: 19894100
references.citation: Fertil Steril. 2011 Aug;96(2):498-500.e1
references.pmid: 21704313
references.citation: Cephalalgia. 1988;8 Suppl 7:1-96
references.pmid: 3048700
references.citation: Headache. 1991 May;31(5):298-301
references.pmid: 1860787
references.citation: Neurology. 2002 Dec 10;59(11):1677-81
references.pmid: 12481795
references.citation: Expert Opin Pharmacother. 2011 Aug;12(12):1933-43
references.pmid: 21726161
references.citation: Continuum (Minneap Minn). 2012 Aug;18(4):835-52
references.pmid: 22868545
references.citation: J Headache Pain. 2011 Dec;12(6):609-15
references.pmid: 21842274
references.citation: CNS Drugs. 2012 Sep 1;26(9):791-811
references.pmid: 22900951
references.citation: Neurology. 2004 Jul 27;63(2):261-9
references.pmid: 15277618
references.citation: Cephalalgia. 2004;24 Suppl 1:9-160
references.pmid: 14979299
references.citation: Curr Pain Headache Rep. 2012 Oct;16(5):445-51
references.pmid: 22644903
references.citation: Headache. 2012 May;52 Suppl 1:8-11
references.pmid: 22540198